Firefly Neuroscience AIFF
NASDAQ AIFF
$1.13 +0.03 (+2.73%)
At close: Sep 4, 2026 · 4:00 PM EDT

Firefly Neuroscience (AIFF) Acquisitions (2021 - 2024)

Firefly Neuroscience (AIFF) posted Acquisitions of $75000.0 for Q3 2024, down 98.51% on a QoQ basis from $5.0 million in Q4 2021.

Analysis

Firefly Neuroscience (AIFF) Acquisitions (2021 - 2024) Analysis & Trends

Firefly Neuroscience has reported Acquisitions for 2 years, with the latest figure at $75000.0 in Q3 2024.

  • On a quarterly basis, Acquisitions changed N/A year-over-year to $75000.0 in Q3 2024; TTM through Dec 2025 was $75000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2.4 million, up 3706.45% from the prior year.
  • Acquisitions was $75000.0 for Q3 2024 at Firefly Neuroscience, down from $5.0 million in the prior quarter.
  • The five-year high for Acquisitions was $5.0 million in Q4 2021, with the low at $75000.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 GE HealthCare Technologies 31.10 Bn 29.22 Bn 2.18 Bn -4.00 Mn
2 Lantheus Holdings 6.59 Bn 6.00 Bn 241.86 Mn -312,000.00
3 Heartflow 4.24 Bn 3.87 Bn 53.19 Mn -
4 Neogen 2.58 Bn 2.39 Bn 107.80 Mn -
5 Butterfly Network 1.75 Bn 1.62 Bn 23.29 Mn -
6 QuidelOrtho 954.15 Mn 830.75 Mn - -
7 Ceribell 944.88 Mn 815.62 Mn 25.94 Mn -
8 Anbio Biotechnology 941.05 Mn 929.15 Mn - -
9 Varex Imaging 780.16 Mn 694.86 Mn 76.70 Mn -
10 Firefly Neuroscience 23.25 Mn 14.03 Mn 253,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 75,000.00
Dec 31, 2021 5.04 Mn